Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Iconiq VCs spent two years courting Chime and the firm isn’t selling its stake

From TechCrunch

By Julie Bort

June 13, 2025

Iconiq VCs spent two years courting Chime and the firm isn’t selling its stake

Iconiq VCs spent two years courting Chime and the firm isn’t selling its stake

The VC tech world was abuzz on Thursday when neobank Chime successfully became a public company. Chime raised $864 million on its $27 share price, which popped big, opening at $43. 

This wasn’t the biggest IPO of the year. CoreWeave, for instance, raised $1.5 billion in March, and its first-day market cap hit around $14 billion, too. (Its share price and valuation has soared since then.)

However, Chime’s cap table includes an absolute who’s who of Silicon Valley investors, many of whom are publicly and privately celebrating the win for their portfolio company. 

This includes Iconiq’s Yoonkee Sull. He and his venture investing partner at Iconiq, Greg Stanger, spent two years watching and pursuing Chime before writing a check, Sull told TechCrunch.

Iconiq is, of course, well known in the Valley as the family office to some of the industry’s most celebrated billionaires, like Mark Zuckerberg. With $80 billion of assets under management, it invests in everything from stocks to real estate, and also has a venture capital arm. Its portfolio includes Benchling, Canva, Databricks, Glean, Notion, and Ramp. If you’ve heard of a company, Iconiq probably has a stake.

Sull said that he and Stanger first met Chime co-founders Chris Britt and Ryan King in 2017. They even went to the Chime offices for the meeting, not the other way around. Iconiq’s VCs tend to prefer outbound deals with well-vetted founders, rather than inbound pitch-to-us sessions.

Still, to have Iconiq come calling just a year after Britt and King’s humbling 2016 was quite the turnaround. Chime was running out of cash in 2016. King had been desperate to raise and was turned down by over 100 VCs, he told TechCrunch. Lauren Kolodny, then a partner at Aspect Ventures, today a co-founder of Acrew Capital, saved the company with a $9 million Series A extension round.

Sull admits that that casual 2017 meeting “was early days at that point in time, but I think what they wanted to accomplish and do was crystal clear,” Sull says of the founders. Chime positions itself as banking and credit-building resources for the average person and working class — the ironic opposite from Iconiq’s bread-and-butter wealth management business.

As the VCs watched the founders over the next two years “deliver against the things that they said they would do,” Sull says, Iconiq was convinced to elbow into Chime’s oversubscribed $200 million Series D in 2019. Series D investors paid $5.22 a share, Chime disclosed in its S-1 filings.

“When we made our investment in 2019 there were quite literally a couple dozen other competitors going after a similar thesis or idea,” Sull said. Iconiq chose Chime, and participated in follow-in rounds, because the investors thought the founders were more focused and didn’t get distracted by “shiny new objects.” 

For follow-on rounds, Series E investors paid about $17, Series F was about $41 a share, and $69 for Series G, Chime disclosed. So even with a solid IPO, not all the private shares are above water yet.

Sull wouldn’t comment on how much Iconiq paid for its stake, which is not large enough to be publicly disclosed. But he did say Iconiq didn’t want to liquidate.

“We have our shares, and we’re not selling in the IPO,” he said. Existing shareholders, including employees, are now subject to a 180-day lock-up period, too. 

Iconiq is one of many of Chime’s backers taking a victory lap at Chime’s graduation to become a public company. Investor Shawn Carolan, from Menlo Ventures, wrote in his congrats blog post: “As with most consumer tech winners, what may have looked to some like an overnight success story was actually many hard years in the making.”

Then there’s Cathay Innovation, which led Chime’s $15 million Series B in 2017 and happily sold 3.75 million shares in the IPO of its 15.3 million share stake. Series B shares were priced at 47 cents, Chime disclosed. 

Correction: This story has been updated to correct an error in the price per share information for Series E, F, and G.

View original article on techcrunch.com

Most Recent

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open-weight AI models for coding.

Jul 17, 2026

Daniel Ek’s body-scanning startup Neko Health raises another $700M

Daniel Ek’s body-scanning startup Neko Health raises another $700M

Neko Health has developed proprietary body-scanning technology, which it couples with bloodwork, to assess a person's health.

Jul 15, 2026

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

General Catalyst’s Customer Value Fund doesn't make equity investments. It's providing $1 billion for IM8, known for its longevity vitamin drink.

Jul 14, 2026

Similar Posts

Chime almost died in 2016, turned down by 100 VCs

Chime almost died in 2016, turned down by 100 VCs

One of the year's most anticipated IPOs took place on Thursday when neobank Chime raised 64 million in its IPO, pricing its shares at 7, which is above its previously announced range of 4 to 6.

Jun 12, 2025

From Skims to Stripe, here are the startups that are likely — or definitely — not having IPOs this year

From Skims to Stripe, here are the startups that are likely — or definitely — not having IPOs this year

Last year’s investor dreams of a strong 2024 IPO pipeline have faded, if not fully disappeared, as we settle in to the second half of the year. This year delivered four venture-backed tech IPOs — Reddit, Astera Labs, Ibotta and Rubrik — in March and April, which made it seem like this year could spur the momentum investors had hoped for in 2023. But secondary investors and IPO lawyers recently told TechCrunch that despite these four successes, macro conditions like the upcoming presidential ele

Aug 7, 2024

Iconiq’s Will Griffith explains how his firm celebrated Figma’s IPO and why investors sold shares

Iconiq’s Will Griffith explains how his firm celebrated Figma’s IPO and why investors sold shares

Will Griffith is a seed investor in Figma. Investors didn't want to sell millions of shares. He explains why they did it anyway.

Jul 31, 2025

$25B-valued Chime files for an IPO, reveals $33M deal with Dallas Mavericks

$25B-valued Chime files for an IPO, reveals $33M deal with Dallas Mavericks

At long last, digital consumer bank Chime has moved forward with its IPO by filing its S-1 paperwork Tuesday. Chime had reportedly filed confidential S-1

May 13, 2025

Most Recent

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open-weight AI models for coding.

Jul 17, 2026

Daniel Ek’s body-scanning startup Neko Health raises another $700M

Daniel Ek’s body-scanning startup Neko Health raises another $700M

Neko Health has developed proprietary body-scanning technology, which it couples with bloodwork, to assess a person's health.

Jul 15, 2026

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

General Catalyst’s Customer Value Fund doesn't make equity investments. It's providing $1 billion for IM8, known for its longevity vitamin drink.

Jul 14, 2026

Similar Posts

Chime almost died in 2016, turned down by 100 VCs

Chime almost died in 2016, turned down by 100 VCs

One of the year's most anticipated IPOs took place on Thursday when neobank Chime raised 64 million in its IPO, pricing its shares at 7, which is above its previously announced range of 4 to 6.

Jun 12, 2025

From Skims to Stripe, here are the startups that are likely — or definitely — not having IPOs this year

From Skims to Stripe, here are the startups that are likely — or definitely — not having IPOs this year

Last year’s investor dreams of a strong 2024 IPO pipeline have faded, if not fully disappeared, as we settle in to the second half of the year. This year delivered four venture-backed tech IPOs — Reddit, Astera Labs, Ibotta and Rubrik — in March and April, which made it seem like this year could spur the momentum investors had hoped for in 2023. But secondary investors and IPO lawyers recently told TechCrunch that despite these four successes, macro conditions like the upcoming presidential ele

Aug 7, 2024

Iconiq’s Will Griffith explains how his firm celebrated Figma’s IPO and why investors sold shares

Iconiq’s Will Griffith explains how his firm celebrated Figma’s IPO and why investors sold shares

Will Griffith is a seed investor in Figma. Investors didn't want to sell millions of shares. He explains why they did it anyway.

Jul 31, 2025

$25B-valued Chime files for an IPO, reveals $33M deal with Dallas Mavericks

$25B-valued Chime files for an IPO, reveals $33M deal with Dallas Mavericks

At long last, digital consumer bank Chime has moved forward with its IPO by filing its S-1 paperwork Tuesday. Chime had reportedly filed confidential S-1

May 13, 2025